Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

PTN Palatin Technologies Inc New

1,827

0,107 (6,22%)

27 Apr 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Palatin Technologies (AMEX:PTN)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Palatin Technologies Charts.

Palatin Technologies (AMEX:PTN)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Palatin Technologies Charts.

News Palatin Technologies Inc New

Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
Montag 8 April 2024 (3 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
Mittwoch 28 Februar 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 15 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Donnerstag 15 Februar 2024 (2 Monate vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 14 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
Freitag 9 Februar 2024 (3 Monate vor) • PR Newswire (US)

Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
Montag 5 Februar 2024 (3 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Palatin Announces Closing of $10 Million Registered Direct Offering
Donnerstag 1 Februar 2024 (3 Monate vor) • PR Newswire (US)

Weitere Palatin Technologies Inc New News-Artikel

Deutsche Telekom (QX)

Deutsche Telekom

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen